123 related articles for article (PubMed ID: 2685695)
1. [Metabolic studies of gliomas with positron emission tomography and phosphorus 31 MR spectroscopy in diagnosis and treatment planning].
Jeske J; Herholz K; Heindel W; Heiss WD
Onkologie; 1989 Aug; 12 Suppl 1():42-5. PubMed ID: 2685695
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
[TBL] [Abstract][Full Text] [Related]
4. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
[TBL] [Abstract][Full Text] [Related]
6. Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.
Imani F; Boada FE; Lieberman FS; Davis DK; Deeb EL; Mountz JM
J Neuroimaging; 2012 Apr; 22(2):184-90. PubMed ID: 21155917
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET.
Herholz K; Ziffling P; Staffen W; Pawlik G; Wagner R; Wienhard K; Heiss WD
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1139-50. PubMed ID: 3262062
[TBL] [Abstract][Full Text] [Related]
8. Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Stanus E; Brotchi J; Hildebrand J
Cancer; 1996 Sep; 78(5):1098-106. PubMed ID: 8780549
[TBL] [Abstract][Full Text] [Related]
9. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
[TBL] [Abstract][Full Text] [Related]
10. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
11. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Tedeschi G; Lundbom N; Raman R; Bonavita S; Duyn JH; Alger JR; Di Chiro G
J Neurosurg; 1997 Oct; 87(4):516-24. PubMed ID: 9322842
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
[TBL] [Abstract][Full Text] [Related]
13. Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.
Nozawa A; Rivandi AH; Kanematsu M; Hoshi H; Piccioni D; Kesari S; Hoh CK
Nucl Med Commun; 2015 Jun; 36(6):573-81. PubMed ID: 25714806
[TBL] [Abstract][Full Text] [Related]
14. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
Song PJ; Lu QY; Li MY; Li X; Shen F
J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
[TBL] [Abstract][Full Text] [Related]
15. [Phosphorus MR spectroscopy and 18F-FDG PET/CT in the study of energy metabolism of glial tumors].
Pronin IN; Batalov AI; Shultz EI; Mertsalova MP; Vikhrova NB; Pogosbekyan EL; Konakova TA; Kornienko VN
Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(2):26-33. PubMed ID: 33864666
[TBL] [Abstract][Full Text] [Related]
16. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
Herholz K; Rudolf J; Heiss WD
J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
18. Glucose uptake by gliomas after treatment. A positron emission tomographic study.
Rozental JM; Levine RL; Nickles RJ; Dobkin JA
Arch Neurol; 1989 Dec; 46(12):1302-7. PubMed ID: 2556096
[TBL] [Abstract][Full Text] [Related]
19. Metabolic response of glioblastoma to adoptive immunotherapy: detection by phosphorus MR spectroscopy.
Ross BD; Tropp J; Derby KA; Sugiura S; Hawryszko C; Jacques DB; Ingram M
J Comput Assist Tomogr; 1989; 13(2):189-93. PubMed ID: 2925904
[TBL] [Abstract][Full Text] [Related]
20. Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas.
Patronas NJ; Brooks RA; DeLaPaz RL; Smith BH; Kornblith PL; Di Chiro G
AJNR Am J Neuroradiol; 1983; 4(3):533-5. PubMed ID: 6410790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
